cannabis indica

Fibrose

termo de indexação original: Fibrosis

O acervo do Cannabis Indica reúne 68 estudos científicos que tocam a condição Fibrose, publicados entre 2005 e 2022. Pela leitura automatizada, 56 (82%) foram classificados como favoráveis, 5 (7%) como inconclusivos e 7 (10%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (32 estudos), seguido de estudo em animais (28). Os compostos mais presentes são Anandamida (AEA), 2-Araquidonoilglicerol (2-AG) e Endocanabinoide (não especificado). Aparece com frequência ao lado de Fibrose — Hepática (Cirrose), Inflamação e Fibrose — Pulmonar.

Estudos indexados
68
Período coberto
2005–2022
Favoráveis
56 · 82%
Inconclusivos
5 · 7%
Desfavoráveis
7 · 10%
Termo original
Fibrosis

O acervo em números

Tipo de estudo

Metanálise32
Estudo em Animais28
Estudo Laboratorial5
Ensaio Clínico3

Direção do resultado

Favorável56
Inconclusivo5
Desfavorável7

Por década

2000s7
2010s34
2020s27

68 estudos

Filtrar e buscar no acervo →
  1. 2022

    Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model

    FavorávelEstudo em AnimaisInflamaçãoObesidadeSíndrome Metabólica+2
  2. 2022

    Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis

    FavorávelEstudo em AnimaisDPOCFibrose — PulmonarEndocanabinoide (não especificado)
  3. 2022

    Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury

  4. 2022

    Formulation and Characterization of O/W Nanoemulsions of Hemp Seed Oil for Protection from Steatohepatitis: Analysis of Hepatic Free Fatty Acids and Oxidation Markers

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoHepatite+2
  5. 2022

    Metabolites of Cannabis Induce Cardiac Toxicity and Morphological Alterations in Cardiac Myocytes

    DesfavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)InfartoToxicidade Cardíaca+2
  6. 2022

    Targeting cannabinoid receptor 2 (CB2) limits collagen production-An in vitro study in a primary culture of human fibroblasts

  7. 2022

    The Effect of Ocimum basilicum L. and Its Main Ingredients on Respiratory Disorders: An Experimental, Preclinical, and Clinical Review

    FavorávelMetanáliseCâncerCâncer — PulmãoAsma+3
  8. 2021

    A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis

    InconclusivoMetanáliseFibrose — Pulmonar
  9. 2021

    Acute lung injury-from cannabis to COVID

    InconclusivoMetanáliseInflamaçãoEfeitos Adversos da CannabisCOVID-19+4
  10. 2021

    AM251, a cannabinoid receptor 1 antagonist, prevents human fibroblasts differentiation and collagen deposition induced by TGF-β - An in vitro study

  11. 2021

    Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension

  12. 2021

    CB1R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome

  13. 2021

    D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-α/NF-κB p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis

    FavorávelEstudo em AnimaisCOVID-19Fibrose — Pulmonar
  14. 2021

    Observed Impact of Long-term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults

    InconclusivoMetanáliseEsteatose HepáticaFibrose — Hepática (Cirrose)
  15. 2021

    Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4-/- Mice

  16. 2021

    The effects of systemic and local fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on the metabolomic profile of lungs

  17. 2021

    The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases

    FavorávelMetanáliseCâncerCOVID-19Câncer — Pulmão+2
  18. 2021

    Therapeutic potential of beta-caryophyllene against aflatoxin B1-Induced liver toxicity: biochemical and molecular insights in rats

    FavorávelEstudo em AnimaisCâncerInflamaçãoEstresse Oxidativo+3
  19. 2021

    Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice

  20. 2020

    A new role for anandamide: defective link between the systemic and skin endocannabinoid systems in hypertrophic human wound healing

  21. 2020

    Cannabinoids and Chronic Liver Diseases

  22. 2020

    Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort)

    FavorávelMetanáliseDiabetesHepatiteFibrose — Hepática (Cirrose)
  23. 2020

    Cannabis Use May Reduce Healthcare Utilization and Improve Hospital Outcomes in Patients with Cirrhosis

    InconclusivoMetanáliseFibrose — Hepática (Cirrose)
  24. 2020

    Cutaneous endocannabinoid system: Does it have a role on skin wound healing bearing fibrosis?

  25. 2020

    Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential?

  26. 2020

    Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review

    FavorávelMetanáliseEstresse OxidativoDiabetesSíndrome Metabólica+1
  27. 2020

    The peripheral CB 1 receptor antagonist JD5037 attenuates liver fibrosis via a CB 1 receptor/β-arrestin1/Akt pathway

  28. 2019

    A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars

    FavorávelMetanáliseDoenças de PelePsoríaseFibrose — Cutânea
  29. 2019

    Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients

    FavorávelMetanáliseEsteatose HepáticaFibrose — Hepática (Cirrose)
  30. 2019

    Cannabis Inhalation and Voice Disorders: A Systematic Review

    DesfavorávelMetanáliseEfeitos Adversos da CannabisFibrose — Pulmonar
  31. 2019

    Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis

  32. 2019

    Opposite roles of cannabinoid receptor 1 and 2 in hepatocarcinogenesis

  33. 2019

    Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications

  34. 2019

    VCE‐004.3, a cannabidiol aminoquinone derivative, prevents bleomycin‐induced skin fibrosis and inflammation through PPARγ‐ and CB2 receptor‐dependent pathways

  35. 2018

    Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease.

    FavorávelMetanáliseCâncerFibrose — Hepática (Cirrose)Câncer — Fígado+2
  36. 2018

    EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis

  37. 2018

    Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver.

    FavorávelEstudo em AnimaisFibrose — Hepática (Cirrose)Monoacilglicerol Lipase (MAGL)
  38. 2018

    Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats.

    FavorávelEstudo em AnimaisFibrose — Hepática (Cirrose)Palmitoiletanolamida (PEA)
  39. 2018

    Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute Inflammation

  40. 2018

    Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis.

    FavorávelMetanáliseFibrose — Hepática (Cirrose)
  41. 2018

    The Role of Cannabinoids in the Setting of Cirrhosis.

  42. 2018

    Use of Cannabis and Risk of Advanced Liver Fibrosis in Patients With Chronic Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis

    DesfavorávelMetanáliseHepatiteFibrose — Hepática (Cirrose)
  43. 2017

    Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice

  44. 2016

    Activation Of Cannabinoid Receptor Type II By AM1241 Ameliorates Myocardial Fibrosis Via Nrf2-Mediated Inhibition Of TGF-β1/Smad3 Pathway In Myocardial Infarction Mice

  45. 2016

    Cannabinoids, Inflammation, and Fibrosis

  46. 2016

    Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors

    FavorávelEstudo em AnimaisFibrose — Hepática (Cirrose)Cúrcuma
  47. 2016

    Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome

  48. 2016

    Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis

    FavorávelEstudo em AnimaisInflamaçãoFibrose — PulmonarPalmitoiletanolamida (PEA)
  49. 2015

    The effect of acute alcohol intoxication on gut wall integrity in healthy male volunteers; a randomized controlled trial

  50. 2014

    Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C

  51. 2013

    Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro

    FavorávelEstudo em AnimaisFibrose — Hepática (Cirrose)Cúrcuma
  52. 2013

    Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis.

    InconclusivoMetanáliseHIV/AIDSHepatiteFibrose — Hepática (Cirrose)
  53. 2012

    Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1

  54. 2012

    The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes

    FavorávelEstudo LaboratorialFibrose — Hepática (Cirrose)N-Araquidonoil Dopamina (NADA)
  55. 2011

    Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis

  56. 2011

    Endocannabinoids in Liver Disease

  57. 2011

    Influence of Cannabis Use on Severity of Hepatitis C Disease.

    DesfavorávelMetanáliseHepatiteFibrose — Hepática (Cirrose)
  58. 2011

    Recent advances in the understanding of the role of the endocannabinoid system in liver diseases

  59. 2011

    Targets of curcumin

    FavorávelMetanáliseCâncerInflamaçãoDoenças Cardiovasculares (DCV)Cúrcuma+16
  60. 2010

    Endocannabinoids and their role in fatty liver disease

  61. 2010

    Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis

  62. 2009

    Cannabidiol Ameliorates Cognitive And Motor Impairments In Mice With Bile Duct Ligation

    FavorávelEstudo em AnimaisCâncerDisfunção CognitivaEsteatose Hepática+2
  63. 2009

    Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis.

    FavorávelEstudo em AnimaisFibrose — Hepática (Cirrose)EsquistossomoseAnandamida (AEA)
  64. 2008

    Endocannabinoids in liver disease and hepatic encephalopathy

  65. 2008

    Role of cannabinoids in chronic liver diseases

  66. 2008

    The endocannabinoid system as a novel target for the treatment of liver fibrosis.

  67. 2005

    Antifibrogenic role of the cannabinoid receptor CB2 in the liver.

  68. 2005

    Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.

    DesfavorávelMetanáliseHepatiteFibrose — Hepática (Cirrose)

Continue por aqui

Perguntas frequentes

Quantos estudos sobre fibrose estão indexados no acervo?
São 68 estudos, publicados entre 2005 e 2022. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 32 · Estudo em Animais: 28 · Estudo Laboratorial: 5 · Ensaio Clínico: 3. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 56 favoráveis, 5 inconclusivos e 7 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Fibrose — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/fibrose/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Fibrose — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/fibrose/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.